The same case could apply to the simultaneous use of metformin and A.C.E. inhibitors, as evidence suggested that the use of metformin, another antidiabetic drug, and renin-angiotensin system inhibitor were associated with lower severity and mortality in COVID-19 patients [14,61]. Here, REN is linked to COVID-19.